Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04215978
Title Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors BeiGene
Indications

Advanced Solid Tumor

Therapies

BGB-A445 + Tislelizumab

BGB-A445

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.